British Gynaecological Cancer Society (BGCS) vulval cancer guidelines: Recommendations for practice

This publication has 134 references indexed in Scilit:

• Management of patients with vulvar cancer: a perspective review according to tumour stage
  Therapeutic Advances in Medical Oncology, 2013
• Vulvar intraepithelial neoplasia (VIN 2/3): Comparing clinical outcomes and evaluating risk factors for recurrence
  Gynecologic Oncology, 2012
• Effect of the human papillomavirus (HPV) quadrivalent vaccine in a subgroup of women with cervical and vulvar disease: retrospective pooled analysis of trial data
  BMJ, 2012
• Prognostic Value of Pathological Resection Margin Distance in Squamous Cell Cancer of the Vulva
  Annals of Surgical Oncology, 2011
• Impact of Human Papillomavirus (HPV)-6/11/16/18 Vaccine on All HPV-Associated Genital Diseases in Young Women
  JNCI: Journal of the National Cancer Institute, 2010
• Phase II study on paclitaxel in patients with recurrent, metastatic or locally advanced vulvar cancer not amenable to surgery or radiotherapy: a study of the EORTC-GCG (European Organisation for Research and Treatment of Cancer—Gynaecological Cancer Group)
  Annals of Oncology, 2009
• Vulvar Cancer and the Need for Awareness of Precursor Lesions
  Journal of Lower Genital Tract Disease, 2009
• Vulvar squamous cell carcinoma development after diagnosis of VIN increases with age
  European Journal of Cancer, 2009
• Is it beneficial to selectively boost high-risk tumor subvolumes? A comparison of selectively boosting high-risk tumor subvolumes versus homogeneous dose escalation of the entire tumor based on equivalent EUD plans
  Acta Oncologica, 2008
• Is the assumed natural history of vulvar intraepithelial neoplasia III based on enough evidence? A systematic review of 3322 published patients
  Gynecologic Oncology, 2005